Transvaginal ultrasound and diagnostic hysteroscopy as a predictor of endometrial polyps: Risk factors for premalignancy and malignancy

International Journal of Gynecological Cancer

Volumn 15, Issue 2, 2005, Pages 325-328

  Machtinger, R ^a   Korach, J ^a   Padoa, A ^a   Fridman, E ^a   Zolti, M ^a   Segal, J ^a   Yefet, Y ^a   Goldenberg, M ^a   Ben Baruch, G ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Endometrial carcinoma; Endometrial polyp; Hysteroscopy; Transvaginal ultrasound

Indexed keywords

TAMOXIFEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; ENDOMETRIUM CARCINOMA; EVALUATION; FEMALE; HUMAN; HYSTEROSCOPY; INCIDENCE; MAJOR CLINICAL STUDY; MENOPAUSE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POPULATION MODEL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TRANSVAGINAL ECHOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIUM; FEMALE; HUMANS; HYSTEROSCOPY; MIDDLE AGED; POLYPS; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; PREMENOPAUSE; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; UTERINE DISEASES; UTERINE NEOPLASMS; VAGINA;

EID: 15444374751     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2005.15224.x     Document Type: Article

References (15)

1. Savelli L, De Iaco P, Santini D et al. Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps. Am J Obstet Gynecol 2003; 188:927-31.
2. Berliere M, Charles A, Galant C et al. Uterine side effects of tamoxifen: a need for systematic pretreatment screening. Obstet Gynecol 1998;91:40-4.
3. Perez-Medina T, Martinez O, Folgueira G, Bajo J. Which endometrial polyps should be resected? J Am Assoc Gynecol Laparosc 1999;6:71-4.
4. Epstein E, Ramirez A, Skoog L et al. Dilatation and curettage fails to detect most focal lesions in the uterine cavity in women with postmenopausal bleeding. Acta Obstet Gynecol Scand 2001;80:1131-6.
5. Bakour SH, Khan KS, Gupta JK. The risk of pre-malignant and malignant pathology in endometrial polyps. Acta Obstet Gynecol Scand 2000;79:317-20.
6. Goldstein SR, Zeltser I, Horan CK et al. Ultrasonography-based triage for perimenopausal patients with abnormal uterine bleeding. Am J Obstet Gynecol 1997;177:102-8.
7. Motashaw ND, Dave S. Complications of hysteroscopy. Gynecol Endosc 2001;10:203-10.
8. Davidson KG, Dubinsky TJ. Ultrasonographic evaluation of the endometrium in postmenopausal vaginal bleeding. Radiol Clin North Am 2003;41:769-80.
9. Guven MA, Bese T, Demirkiran F. Comparison of hydrosonography and transvaginal ultrasonography in the detection of intracavitary pathologies in women with abnormal uterine bleeding. Int J Gynecol Cancer 2004;14:57-63.
10. Wolfe SA, Mackles A. Malignant lesions arising from benign endometrial polyps. Obstet Gynecol 1962;20:542-50.
11. Goldstein SR, Monteagudo A, Popiolek D et al. Evaluation of endometrial polyps. Am J Obstet Gynecol 2002;186:669-74.
12. De Wit AC, Vleugels MP, de Kruif JH. Diagnostic hysteroscopy: a valuable diagnostic tool in the diagnosis of structural intra-cavital pathology and endometrial hyperplasia or carcinoma? Six years of experience with non-clinical diagnostic hysteroscopy. Eur J Obstet Gynecol Reprod Biol 2003;110:79-82.
13. Orvieto R, Bar-Hava I, Dicker D et al. Endometrial polyps during menopause: characterization and significance. Acta Obstet Gynecol Scand 1999;78:883-6.
14. Timmerman D, Deprest J, Verbesselt R et al. Absence of correlation between risk factors for endometrial cancer and the presence of tamoxifen-associated endometrial polyps in postmenopausal patients with breast cancer. Eur J Cancer 2000;36(Suppl. 4):S40-2.
15. Bakour SH, Khan KS, Gupta JK. The risk of premalignant and malignant pathology in endometrial polyps. Acta Obstet Gynecol Scand 2002;81:182-3.